| |
|
|
|
BioCryst Pharmaceuticals- Inc.  
|
|
6.0999 -0.08 (-0.01%) |
07-19 15:09 |
|
Open: |
6.18 |
Pre close: |
6.18 |
Target:
|
7.81
|
|
High: |
6.24 |
Low: |
6.0799 |
Resistance:
|
6.69
7.81
|
|
Volume: |
342,344 |
Market Cap: |
602M |
Support:
|
5.86
5.34
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.21
 |
MACD |
MACD(12,26):
|
0.10  |
|
MA(20): |
5.94 |
Signal(12,26,9): |
0.08 |
|
MA(100): |
5.51 |
Stochastic Oscillator |
%K(14,3):
|
59.26 |
|
MA(250): |
5.17 |
%D(3): |
62.41 |
|
Average Volume(K) |
3-Month: |
78312
|
52-Week |
High:
|
6.69 |
|
10-Days: |
65493 |
Low: |
3.95 |
|
RSI |
RSI(14):
|
54.51 |
Change(%): |
12.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.850 |
Return on Equity (ttm) |
-153.8 |
Shares Out. (M) |
98.72 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-54.3 |
Shares Float (M) |
94.63 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
-0.32 |
% Held by Insiders |
4.10 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-57.9 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-0.900 |
Gross Profit (p.s.) |
0.107 |
Shares Short (K) |
9903 |
|
Book Value (p.s.) |
9.660 |
EBITDA (p.s.) |
-0.278 |
P/E |
-7.18 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.63 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-52.27 |
P/S |
2737236224.00 |
|
Operating Margin |
-325.68 |
Levered Free Cash Flow
(M) |
-18.25 |
P/CF |
-11.52 |
|
|
|
|
|
|
